Patrick Gérardin
National Institutes of Health
2 Papers
Patrick Gérardin is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Internal medicine & Neuraminidase. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.
Stella G. Muthuri,Sudhir Venkatesan,Puja R. Myles,Jo Leonardi-Bee,Tarig Saleh Al Khuwaitir,Adbullah Al Mamun,Ashish P Anovadiya,Eduardo Azziz-Baumgartner,Clarisa Báez,Matteo Bassetti,Bojana Beović,Barbara Bertisch,Isabelle Bonmarin,Robert Booy,Víctor Hugo Borja-Aburto,Heinz Burgmann,Bin Cao,Jordi Carratalà,Justin T Denholm,Samuel R. Dominguez,Péricles Almeida Delfino Duarte,Gal Dubnov-Raz,Marcela Echavarria,Sergio Fanella,Zhancheng Gao,Patrick Gérardin,Maddalena Giannella,Sophie Gubbels,Jethro Herberg,A. Iglesias,Peter Höger,Xiaoyun Hu,Quazi Tarikul Islam,Mirela Foresti Jiménez,Amr Kandeel,Gerben Keijzers,Hossein Khalili,Marian Knight,Koichiro Kudo,Gabriela Kusznierz,Ilija Kuzman,Arthur M C Kwan,Idriss Lahlou Amine,Eduard Langenegger,Kamran Bagheri Lankarani,Yee-Sin Leo,Rita Linko,Pei Liu,Faris Madanat,Elga Mayo-Montero,Allison McGeer,Ziad A. Memish,Gökhan Metan,Auksė Mickiene,Dragan Mikić,Kristin G.-I. Mohn,Kristin G.-I. Mohn,Ahmadreza Moradi,Ahmadreza Moradi,Pagbajabyn Nymadawa,Maria E. Oliva,Mehpare Ozkan,Dhruv Parekh,Mical Paul,Fernando P. Polack,Barbara Rath,Alejandro Rodríguez,Elena B. Sarrouf,Anna C. Seale,Anna C. Seale,Bunyamin Sertogullarindan,Marilda M. Siqueira,Joanna Skręt-Magierło,Frank P. Stephan,Ewa Talarek,Julian W. Tang,Julian W. Tang,Kelvin K. W. To,Antoni Torres,Selda Hançerli Törün,Dat Tran,Timothy M. Uyeki,Annelies van Zwol,Wendy Vaudry,Tjasa Vidmar,Renata T. C. Yokota,Paul Zarogoulidis,Jonathan S. Nguyen-Van-Tam +87 more
TL;DR: There was an increase in the mortality hazard rate with each day's delay in initiation of treatment up to day 5 as compared with treatment initiated within 2 days of symptom onset, and early treatment versus no treatment was also associated with a reduction in mortality risk.
632
Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.
Sudhir Venkatesan,Puja R. Myles,Kirsty J. Bolton,Stella G. Muthuri,Al Khuwaitir T,Ashish P Anovadiya,Azziz-Baumgartner E,Tahar Bajjou,Matteo Bassetti,Bojana Beović,Barbara Bertisch,Isabelle Bonmarin,Robert Booy,Víctor Hugo Borja-Aburto,Heinz Burgmann,Bin Cao,Jordi Carratalà,Chinbayar T,Catia Cilloniz,Justin T Denholm,Dominguez,Duarte Pad,Gal Dubnov-Raz,Sergio Fanella,Zhancheng Gao,Patrick Gérardin,Maddalena Giannella,Sophie Gubbels,Jethro Herberg,Higuera Iglesias Al,Peter H. Hoeger,Xiaoyun Hu,Quazi Tarikul Islam,Mirela Foresti Jiménez,Gerben Keijzers,Hossein Khalili,Gabriela Kusznierz,Ilija Kuzman,Eduard Langenegger,Kamran Bagheri Lankarani,Yee-Sin Leo,Romina Libster,Rita Linko,Faris Madanat,Maltezos E,Adbullah Al Mamun,Toshie Manabe,Gökhan Metan,Auksė Mickiene,Dragan Mikić,Mohn Kgi,Maria E. Oliva,Mehpare Ozkan,Dhruv Parekh,Mical Paul,Barbara Rath,S.A.M. Refaey,Rodríguez Ah,Bunyamin Sertogullarindan,Joanna Skręt-Magierło,Ayper Somer,Ewa Talarek,Julian W. Tang,Kelvin K. W. To,Tran D,Timothy M. Uyeki,Wendy Vaudry,Tjasa Vidmar,Paul Zarogoulidis,Jonathan S. Nguyen-Van-Tam +69 more
TL;DR: When patients hospitalized with influenza are treated with NAIs, treatment initiated on admission, regardless of time since symptom onset, is associated with a reduced LoS, compared with later or no initiation of treatment.